Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $4.19 Million - $4.89 Million
27,062 New
27,062 $4.64 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $3.82 Million - $4.3 Million
27,727 New
27,727 $4.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Arbor Capital Management Inc Portfolio

Follow Arbor Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arbor Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Arbor Capital Management Inc with notifications on news.